Form 4: AN2 Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Sarah Joanne Williams, Principal Accounting Officer of AN2 Therapeutics, Inc., sold 272 shares of common stock on September 1, 2026 for $5.53 per share.
Summary
- Open-market sale: disposed of 272 Common Stock at $5.53 ($1,504) on September 1, 2026; holds 66,311 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,504 of stock on the open market.
Insider Transactions
Sarah Joanne Williams — Officer (Principal Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Open-market sale | Common Stock | 272 | $6 | $1.5K | 66,311 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Open-market sale (272 shares) |
Keywords
insider transaction, Form 4, ANTX, AN2 Therapeutics, Inc., bearish, Sarah Joanne Williams
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.